Pooph Pet Odor Eliminator, 32oz Spray - Dismantles Odors on a Molecular Basis, Dogs, Cats, Freshener, Eliminator, Urine, Poop, Pee, Deodorizer, Natures, Puppy, Fresh, Clean, Furniture, Potty, Safe https://www.amazon.com/dp/B09PF4KVHJ/ref=cm_sw_r_awdo_ERJ9R722N5QHW7ZK2BJY
As Pet Ownership In U.S. Skyrockets, Two Companies Join Forces To Say "Pooph" To Household Odor March 21, 2022 https://www.benzinga.com/markets/pe...es-join-forces-to-say-pooph-to-household-odor Ikigai Marketing Works, LLC is composed of consumer product marketing executives with experience launching and growing multiple blockbuster consumer products including Oxiclean, Flawless, and Copperfit. Ikigai was responsible for developing the Pooph™ brand and produced new television commercials and other advertising content to help boost the brand. The company recently conducted a television direct-response test marketing campaign to assess the Pooph™ probability of being a commercial success. BioLargo CEO Dennis Calvert said, "We manufacture the PoophTM product for Ikigai and we receive a royalty on sales and 20% of any eventual exit. Ikigai will finance and manage product rollout, distribution, and marketing. We are excited about the potential to create significant new revenue for both parties.”
"We expect to make a big splash in the immediate future with our Aqueous Electrostatic Concentrator (AEC) PFAS treatment system, including with new channel partnerships, and we soon expect to secure our first commercial accounts with our Advanced Oxidation System (AOS) energy-efficient water treatment technology."" BioLargo Annual Report for 2021 Highlights Active Commercial Catalysts, Expanding Partnerships, and Improved Balance Sheet March 31, 2022 https://feeds.issuerdirect.com/news-release.html?newsid=8703956065857867
The most important information from the video in my previous post. Obviously great times ahead Ikigai partnership: BioLargo established a partnership with Ikigai Marketing Works, LLC to support the roll-out of a new pet odor control product based on BioLargo's proprietary technology, ultimately aimed at adoption by big-box retailers. Ikigai completed a test-marketing phase to assess the likelihood that the new brand would be a commercial success and subsequently made orders for product (manufactured by BioLargo) that exceed both partners' initial projections. BioLargo also earns a royalty on each bottle sold and would receive 20% of any eventual sale of the product line. Ikigai's sales are growing.
BioLargo Continues Growth Trend by Breaking Quarterly Revenue Record WESTMINSTER, CA / ACCESSWIRE April 20, 2022 https://feeds.issuerdirect.com/news-release.html?newsid=5591198634826761 New company-wide quarterly revenue record BioLargo generated approximately $900,000 in revenue (company-wide) for the first quarter of 2022, representing an approximate 60% increase compared with the same period in 2021. Leading the way was subsidiary ONM Environmental with a new quarterly revenue record of approximately $550,000, and BioLargo's engineering subsidiary with quarterly revenue of approximately $350,000, while it continued to support R&D on the company's patented technologies. With these revenues, each of ONM Environmental and BioLargo Engineering moved closer to generating an operating profit. Note however, these preliminary revenue figures have not been reviewed, and are subject to change pending review by the company's independent registered public accounting firm; the company will include its full results of operations in its quarterly report, which it intends to file with the SEC on about May 16, 2022. Feasibility contract awarded for potential large waste-to-energy conversion plant project Randall Moore, President of BioLargo Engineering, Science & Technologies, said, "The development of this waste-to-energy conversion plant is directly in our wheelhouse of past experience and knowledge. To process two million tons of municipal solid waste per year, the total capital outlay by the developer for a processing plant of that size could exceed $500 million, with the potential to keep our team busy for the next four years." Dennis P. Calvert, President and CEO of BioLargo, commented, "We look forward to sharing additional information as this project advances. We are continuing our strategy of employing strategic partnerships to develop new revenue channels for our cleantech products and services. As we referenced in our recently published annual report, we have additional channel partnerships in various stages of negotiation for our PFAS treatment system and are eager to provide more information soon. When combined with our other partnerships aimed at delivering cleantech solutions, including with Garratt-Callahan and Ikigai, we believe these record revenues are the beginning of what we believe will be accelerated growth for our company."
BioLargo Inc presenting at the One2One Forum 26th April 2022 April 26, 2022 BioLargo Inc invents, develops, and commercializes innovative platform technologies to solve challenging environmental problems like PFAS contamination, advanced water and wastewater treatment, industrial odor and VOC control, air quality control, and infection control.
BioLargo's First Quarterly Report of 2022 Highlights: Record Company-wide Revenues, Subsidiaries Achieving and Approaching Profitability, and Progress of Key Growth Catalysts WESTMINSTER, CA / ACCESSWIRE / May 17, 2022 / BioLargo, Inc. (OTCQB:BLGO), a developer of sustainable cleantech technologies and full-service environmental engineering company, filed its Quarterly Report on Form 10-Q for the period ended March 31, 2022, with the SEC yesterday (www.biolargo.com/sec-filings). Here the company has provided highlights from the report as well as commentary on the company's strategy for growth. "BioLargo is at a turning point," said the company's President and CEO, Dennis P. Calvert. "After investing years and millions of dollars into R&D for our innovative technologies, in this quarter we generated record revenues, our subsidiary ONM Environmental turned an operating profit, and our engineering subsidiary ended the quarter just shy of profitability. Although we have solidified our reputation as a trusted and credible cleantech solutions provider thanks to our commitment to creating best-in-class sustainable technologies and our growing roster of talented engineers and scientists, we still must work hard to continue to achieve these results in the long term. Now we are capitalizing on these assets in a way we believe will create significant value for our company and stockholders." https://feeds.issuerdirect.com/news-release.html?newsid=8923436545482856
BioLargo, Inc. Discusses Record-Breaking Quarter on The Stock Day Podcast Newsfile Corp. Mon, May 23, 2022, https://feeds.issuerdirect.com/news-release.html?newsid=7951764878445078 Phoenix, Arizona--(Newsfile Corp. - May 23, 2022) - The Stock Day Podcast welcomed BioLargo, Inc. (OTCQB: BLGO), a company that invents, develops, and commercializes innovative technologies in the cleantech space, including for PFAS contamination, advanced water and wastewater treatment, industrial odor and VOC control, air quality control, and infection control. President and CEO of BioLargo, Dennis P. Calvert, joined Stock Day host Sever Oakley for an interview on the Stock Day Podcast. Oakley began by asking about the company's background and vision. "BioLargo has over a decade of R&D behind it, and we've been inventing chemistries, technical solutions, and all sorts of innovations to help solve some of the biggest problems that face our planet, including clean air, clean water, and a cleaner Earth," explained Calvert. "All of that R&D is beginning to pay off through commercialization." Oakley then commented on the company's recently announced record-breaking quarter and asked about the drivers behind this success. "Most of this is organic growth, so it is a very exciting time," answered Calvert. "It was a 69% growth over last year's quarter," he added, noting that the company brought in nearly a million in revenue in the first quarter of 2022. The conversation then turned to the company's technology that treats water contaminated with per- and polyfluoroalkyl substances (PFAS). Calvert explained, "PFAS are 'forever chemicals' which have been used for about 35 years in all sorts of plastic coatings… PFAS has been linked to adverse health effects, including cancer." He added, "We have an innovation that we believe will be the number one technical solution for concentrating, extracting, and removing those contaminants from nature." "What is the status of your PFAS treatment technology division?" asked Oakley. "We've just completed some testing with one of the largest [municipal water agencies] in the world, and that data and proof of claim has become instrumental," said Calvert. "We achieved what is called a non-detect status, which means the level was so low that it was below the level of being detectable by current technology," he said, before elaborating on the company's growing list of prospects and channel partners, as well as a pipeline of potential projects. Oakley then turned the conversation to BioLargo's partnership with Garratt-Callahan, the largest privately owned water treatment company in North America. The two companies have partnered to bring a new wastewater treatment technology to market. "We have developed a system that has been validated, which we call the Minimum Liquid Discharge (MLD) [system]," said Calvert. "Garratt-Callahan asked us to design, make, and prove up this machine, and in exchange we would become the supply chain partner and they would manage distribution." Calvert discussed the plan for rolling out the MLD system with Garratt-Callahan customers, "We are in current negotiations with customers… It is about a year and a half of work coming to fruition on the commercial side and we're pretty excited about the next few steps." "Could you tell us about the new contract with the waste-to-energy conversion plant project in South America?" asked Oakley. Calvert explained that BioLargo has been contracted for the first phase of the project, a comprehensive project planning stage (i.e., "feasibility study"), and may be hired for additional stages with greater potential value. He finished by adding that if the project advances to completion, the total project cost could reach a half billion dollars over its lifetime of four or more years. To hear Dennis Calvert's entire interview, follow the link to the podcast here: https://audioboom.com/posts/8088354-biolargo-inc-discusses-record-breaking-quarter-on-the-stock-day-podcast
For BioLargo, Cleantech Isn't Just A Tagline by Alex Evans May 31, 2022 https://www.benzinga.com/markets/pe...25/for-biolargo-cleantech-isnt-just-a-tagline
The slides are from the presentation of today's shareholder meeting. In addition to the previously highlighted major business opportunities this company just keeps coming with more https://www.sec.gov/Archives/edgar/data/880242/000143774922014090/ex_383084.htm
Military bases across the country are contaminated with PFAS due to the use of firefighting foam containing the chemicals. Congress has earmarked almost $600 million to clean them up. At least 12 military bases contaminating water supply with toxic PFAS https://www.theguardian.com/us-news/2022/jun/06/military-bases-contaminating-water-supply-pfas
Proactive ONE2ONE #Virtual#Investor Forum - Tuesday 14th June 2022 June 14, 2022 BLGO starts at 58:07 minutes
Sequire Spotlight Presents Biolargo (BLGO): Solutions that Make Life and the Environment Better June 15, 2022 CEO & President, Dennis Calvert, unveils their massive expansion in tackling some of the largest problems facing the environment.
BioLargo Engineering, Science & Technologies Selected to Help Make Novel Nuclear Reactor Fuel Production System June 30, 2022 2:30 PM WESTMINSTER, CA / ACCESSWIRE / June 30, 2022 / BioLargo, Inc. (OTCQB:BLGO), a developer of sustainable cleantech technologies and full-service environmental engineering company, announced that its engineering subsidiary located in Oak Ridge, Tennessee, has been working with Ultra Safe Nuclear to help produce the first prototype fuel production systems for the company's revolutionary new Micro Modular Reactor (MMR®). A Seattle-based nuclear energy innovator, Ultra Safe Nuclear has invented a "fission battery" - a fourth generation modular nuclear reactor - that can deliver safe, zero-carbon, cost-effective energy anywhere. The MMR® uses ceramic-encapsulated nuclear fuel - Fully Ceramic Micro-encapsulated (FCM®) - an extremely rugged and stable fuel with extraordinary high temperature stability. Ultra Safe Nuclear recently opened a facility in Oak Ridge, Tennessee, and reports that it will invest approximately $13 million in the community. The facility is focused on building production systems that can efficiently manufacture the ceramic-encapsulated nuclear fuel used in their reactors. BioLargo Engineering, Science & Technologies (BioLargo Engineering) has been retained to provide engineering design support, fabrication, and integration for the company's prototype fuel production systems. Thus far, BioLargo has been contracted for work in the range of a half million dollars, to be completed over several months. Randall Moore, President of BioLargo Engineering, said, "Ultra Safe Nuclear's reactor represents the cutting edge in clean, safe nuclear energy. At BioLargo, we are focused on sustainable, clean technologies, and we're thrilled to assist in developing the fuel systems for this impressive technology. We look forward to a long and fruitful relationship with Ultra Safe Nuclear." https://feeds.issuerdirect.com/news-release.html?newsid=7521613058652052
August 3, 2022 2:30 PM BioLargo Sets New Quarterly Revenue Record Quarterly Revenues in Q2 Grew 37% Compared to Q1, and 185% Compared to Q2 of 2021 https://feeds.issuerdirect.com/news-release.html?newsid=8252270004891168 BioLargo says it will report record quarterly revenue, with more record quarters to follow August 4, 2022 BioLargo Inc CEO Dennis Calvert says a 37% quarter-over-quarter increase in second-quarter revenue to around $1.3 million is "the culmination of a lot of work". "It really is the moment in which we are seeing some pretty dramatic percentage increases," Calvert told Proactive. In part, Calvert attributed the quarterly gains to expanded sales of pet control products and wastewater treatment technologies. "The number are getting more and more ... meaningful," he added. "Two of our operating units we reported on last quarter were teetering on profitability. We're pretty sure we've now achieved that objective."
BioLargo Achieves 185% Growth to $1.3 Million Revenue for Second Quarter 2022, as Published in Quarterly Report Quarterly Report highlighted by profitable operating subsidiaries, growth of white-label odor product sales, and large engineering projects https://feeds.issuerdirect.com/news-release.html?newsid=8799784260803191 WESTMINSTER, CA / ACCESSWIRE / August 16, 2022 / BioLargo, Inc. (OTCQB:BLGO), a developer of sustainable cleantech technologies and full-service environmental engineering company, filed its Quarterly Report on Form 10-Q for the period ended June 30, 2022, with the SEC yesterday (www.biolargo.com/sec-filings). Here the company has provided highlights from the quarterly report and a discussion of key business initiatives with the most potential to stimulate growth. BioLargo's President and CEO Dennis P. Calvert said, "We are proud of the entire BioLargo team working together and executing on all fronts as we continue growing the business through bigger and better projects. It has been incredible to watch our team land and expand into new client projects through great service and deliverables. PFAS is a major opportunity for us, and we are on the forefront of real environmental impact, working with channel partners to solve some of today's toughest environmental challenges." Financial highlights Company-wide consolidated revenue for the three and six months ended June 30, 2022, was $1,323,000 and $2,287,000, which is a 185% and 121% increase over the same periods in 2021; revenue this quarter was a 37% increase compared with the first quarter of 2022. Revenues from ONM Environmental, the company's odor and VOC control subsidiary, for the three and six months ended June 30, 2022, were $700,000 and $1,300,000, an increase of $344,000 and $658,000, from the same periods in 2021. In the second quarter of 2022, this subsidiary generated a net operating income of $11,000, compared to a net operating loss of $107,000 in the same period of 2021. Revenues from third parties for BioLargo Engineering, Science & Technologies, the company's environmental engineering subsidiary, for the three and six months ended June 30, 2022, were $617,000 and $972,000, an increase of $434,000 and $698,000, from the same periods in 2021. In the second quarter of 2022, this subsidiary generated a net operating income of $56,000, compared to a net operating loss of $190,000 in the same period of 2021. Commercial and developmental highlights First PFAS customer - the company recently secured its first PFAS customer. As part of this project, BioLargo will engineer a comprehensive PFAS mitigation plan for an industrial site, and has signed an agreement with a new channel partner to sell the company's PFAS treatment equipment and engineering services. Ikigai's POOPH - The company's white-label pet odor control product partnership with Ikigai is advancing well and generating increasing revenues both from manufacturing the product and from license royalties. Sales thus far have exceeded early expectations, and the company's partners at Ikigai are confident that growth will continue, especially as they push to get the product onto shelves at major retailers. Garratt-Callahan partnership - The company expects first sales of the "minimal liquid discharge" (MLD) wastewater treatment equipment developed in partnership with Garratt-Callahan to begin soon, following discussions with an expanding list of Garratt-Callahan customers. Larger engineering projects - In this quarter, BioLargo Engineering, Science & Technologies executed engineering projects for new customers, including its project to develop prototypes with Ultra Safe Nuclear, and the waste-to-energy plant project in South America. With both of these projects, early phase work is nearly done, and management anticipates that additional phases will soon begin, with the scope of work and level of engagement expanding.
BioLargo sees 'a major opportunity' for PFAS unit as it reports a surge in second-quarter revenue August 19, 2022 BioLargo Inc (OTCQB:BLGO) CEO Dennis Calvert takes Proactive's Stephen Gunnion through the company's second-quarter results, which show a 185% year-over-year jump in revenue to $1.32 million on the back of strong contributions from its engineering and environmental divisions. Calvert telling Proactive that the company's PFAS (per- and polyfluoroalkyl substances) business is a major opportunity, and BioLargo is at the forefront of real environmental impact, working with channel partners to solve some of today’s toughest environmental challenges.
